QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The significance of Oncotype DX recurrence score in T1-2N1M0 ER positive HER2 negative breast cancer: An analysis combined with the prognostic stage in the updated AJCC 8th edition 会议论文 作者:  Zhang, M.;  Chen, H.;  Wang, M.;  Zhang, P.;  Wu, K. 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients 期刊论文 CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11, 页码: 3153-3162 作者:  Sun, Yi;  Li, Wenqiang;  Li, Ai-Jie;  Su, Huichao;  Yue, Jinbo 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 breast cancer  SII  HER2  inflammation   EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC 期刊论文 Aging-Us, 2019, 卷号: 11, 期号: 23, 页码: 11054-11072 作者:  Y.Liu;  Y.H.Zhou;  K.H.Huang;  Y.Li;  X.J.Fang 收藏  |  浏览/下载：2/0  |  提交时间：2020/08/24 triple-negative breast cancer,human epidermal growth factor receptor,chimeric antigen receptor engineered T cells,negative breast-cancer,growth-factor receptor,therapy,amplification,inhibition,expression,challenges,mutations,her2,Cell Biology,Geriatrics & Gerontology